{"id":"hmg-coa-reductase-inhibitor","safety":{"commonSideEffects":[{"rate":"1-3%","effect":"Myalgia (muscle pain)"},{"rate":"1-3%","effect":"Elevated liver transaminases"},{"rate":"<0.1%","effect":"Rhabdomyolysis (rare)"},{"rate":"1-2%","effect":"Headache"},{"rate":"1-2%","effect":"Gastrointestinal upset"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These drugs competitively inhibit HMG-CoA reductase, the enzyme responsible for converting HMG-CoA to mevalonate in the cholesterol biosynthetic pathway. By reducing intracellular cholesterol levels, they trigger upregulation of LDL receptors on hepatocytes, increasing clearance of LDL from the bloodstream. This class is commonly known as statins and is widely used for cardiovascular risk reduction.","oneSentence":"HMG-CoA reductase inhibitors block the enzyme that catalyzes the rate-limiting step of cholesterol synthesis, reducing hepatic cholesterol production and lowering blood LDL cholesterol levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:31:44.641Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and dyslipidemia"},{"name":"Primary and secondary prevention of cardiovascular disease"}]},"trialDetails":[{"nctId":"NCT04067297","phase":"NA","title":"Using Big Data to Conduct Innovative Cardiovascular Clinical Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institute for Clinical Evaluative Sciences","startDate":"2019-10-01","conditions":"Cardiovascular Diseases, Cardiovascular Risk Factor, Dyslipidemias","enrollment":500000},{"nctId":"NCT07089589","phase":"","title":"Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2008-01-02","conditions":"Major Adverse Cardiovascular Events, Liver Transplantation","enrollment":6871},{"nctId":"NCT02968810","phase":"PHASE2","title":"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-21","conditions":"Cirrhosis, Hepatocellular Carcinoma","enrollment":52},{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT07392541","phase":"PHASE1, PHASE2","title":"Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-30","conditions":"Advanced Biliary Tract Carcinoma","enrollment":29},{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT07474649","phase":"PHASE3","title":"A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events","status":"NOT_YET_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2026-06-01","conditions":"Coronary Atherosclerosis, Mixed Dyslipidemia, Hypercholesterolemia","enrollment":103},{"nctId":"NCT04862260","phase":"EARLY_PHASE1","title":"Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2021-10-04","conditions":"Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer","enrollment":3},{"nctId":"NCT07400757","phase":"NA","title":"Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2026-02-20","conditions":"Thyroid Eye Disease, TED, Graves Ophthalmopathy","enrollment":120},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT07045142","phase":"PHASE3","title":"Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-07-01","conditions":"Schizophrenia","enrollment":400},{"nctId":"NCT07460960","phase":"PHASE2","title":"TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men","status":"RECRUITING","sponsor":"Lomonosov Moscow State University Medical Research and Educational Center","startDate":"2026-03-05","conditions":"Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction","enrollment":150},{"nctId":"NCT06062394","phase":"NA","title":"Penn Medicine Healthy Heart","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-03-11","conditions":"Hypertension, Hyperlipidemias","enrollment":1980},{"nctId":"NCT07464574","phase":"","title":"Optimizing Non-statin Agents for ASCVD","status":"RECRUITING","sponsor":"University of Texas at Austin","startDate":"2026-01-16","conditions":"ASCVD Management","enrollment":1000},{"nctId":"NCT07459972","phase":"PHASE4","title":"Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-03-15","conditions":"Liver Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":22},{"nctId":"NCT07359105","phase":"NA","title":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","status":"RECRUITING","sponsor":"Sin Gon Kim","startDate":"2026-03-09","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2186},{"nctId":"NCT07462715","phase":"PHASE4","title":"Statins Against Bushfire Smoke","status":"NOT_YET_RECRUITING","sponsor":"Menzies Institute for Medical Research","startDate":"2026-05-01","conditions":"Healthy Adults","enrollment":100},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT04915183","phase":"PHASE2","title":"Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer","status":"RECRUITING","sponsor":"National Institute on Deafness and Other Communication Disorders (NIDCD)","startDate":"2024-07-10","conditions":"Hearing Loss, Head and Neck Cancer","enrollment":224},{"nctId":"NCT05360446","phase":"PHASE3","title":"Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-07-08","conditions":"Coronary Artery Disease","enrollment":610},{"nctId":"NCT07102628","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-10-03","conditions":"Acute Coronary Syndrome","enrollment":300},{"nctId":"NCT07447206","phase":"PHASE2","title":"Vascular Intervention Strategies Trial for Alzheimer's","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-03","conditions":"Hypertension, Hypercholesterolemia, Dementia Risk Factors","enrollment":10},{"nctId":"NCT03269058","phase":"PHASE4","title":"Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2017-12-20","conditions":"Type-2 Diabetes, Oral Antidiabetics","enrollment":28},{"nctId":"NCT05586360","phase":"PHASE2","title":"T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-03-11","conditions":"Prostate Cancer","enrollment":36},{"nctId":"NCT07447648","phase":"","title":"Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)","status":"NOT_YET_RECRUITING","sponsor":"Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)","startDate":"2026-03","conditions":"Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography","enrollment":52},{"nctId":"NCT07445581","phase":"NA","title":"Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Jinggang Xia, MD","startDate":"2026-02-28","conditions":"Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis","enrollment":480},{"nctId":"NCT07217938","phase":"PHASE2","title":"Novel Treatment of Radiation Associated Dysphagia With Statins","status":"RECRUITING","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2025-12-05","conditions":"Radiation-associated Dysphagia, Head &Amp; Neck Cancer","enrollment":48},{"nctId":"NCT04098003","phase":"PHASE4","title":"Investigation of the Gut Microbiome and Statin Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sony Tuteja","startDate":"2020-02-06","conditions":"Healthy Volunteers","enrollment":62},{"nctId":"NCT07445542","phase":"","title":"Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2021-12-18","conditions":"Hypercholesterolemia","enrollment":6927},{"nctId":"NCT06696820","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Xiang Luo","startDate":"2024-11-29","conditions":"Acute Ischemic Stroke","enrollment":429},{"nctId":"NCT06488105","phase":"PHASE2","title":"Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-08-05","conditions":"Lipid Disorder, Hypercholesterolemia, Cardiovascular Diseases","enrollment":130},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT05912387","phase":"EARLY_PHASE1","title":"Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-05-31","conditions":"Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases","enrollment":15},{"nctId":"NCT06538649","phase":"EARLY_PHASE1","title":"Effect of Statins on Crohn's Disease","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-12-12","conditions":"Crohn's Ileocolitis, Crohn Disease","enrollment":20},{"nctId":"NCT05394181","phase":"NA","title":"Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2022-08-01","conditions":"Coronary Artery Disease","enrollment":""},{"nctId":"NCT07440381","phase":"PHASE3","title":"triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE","status":"NOT_YET_RECRUITING","sponsor":"Heart Care Foundation","startDate":"2026-09","conditions":"Acute Coronary Syndromes, Secondary Prevention, Lipids","enrollment":600},{"nctId":"NCT06841536","phase":"NA","title":"Combined Effects of Statins and Exercise on Training Sensitive Health Markers","status":"COMPLETED","sponsor":"University of the Faroe Islands","startDate":"2025-05-01","conditions":"Dyslipidemias","enrollment":120},{"nctId":"NCT06764966","phase":"PHASE2","title":"Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis","status":"RECRUITING","sponsor":"CAMC Health System","startDate":"2025-09-09","conditions":"Decompensated Liver Cirrhosis, Cirrhosis, Decompensated Cirrhosis of Liver","enrollment":50},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT05588895","phase":"NA","title":"Picture of Incidental Calcium To Understand Risk Estimate (PICTURE) Trial","status":"COMPLETED","sponsor":"Stanford University","startDate":"2024-01-08","conditions":"Coronary Artery Calcification","enrollment":202},{"nctId":"NCT07098975","phase":"PHASE2","title":"Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01-14","conditions":"Preeclampsia (PE), Intrauterine Growth Restriction (IUGR), Placental Insufficiency","enrollment":154},{"nctId":"NCT07282756","phase":"NA","title":"Evaluation Of The Efficacy Of Subgingival Application Of Lovastatin Gel As An Adjunct To Non-Surgical Treatment Of Periodontitis In Generally Healthy Smokers And Non-Smokers Patients in Central Europe.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-11","conditions":"Periodontal Diseases, Periodontitis, Periodontal Disease","enrollment":44},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT04975594","phase":"","title":"Statin-Intolerance Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Leipzig","startDate":"2021-08-01","conditions":"Dyslipidemias","enrollment":1000},{"nctId":"NCT05743387","phase":"NA","title":"Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-05-13","conditions":"Type 2 Diabetes Mellitus (T2D)","enrollment":252},{"nctId":"NCT05289063","phase":"PHASE1","title":"Vascular Endothelial Dysfunction in Sleep Apnea","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-10-03","conditions":"Obstructive Sleep Apnea of Adult","enrollment":110},{"nctId":"NCT07404553","phase":"PHASE2, PHASE3","title":"A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors","status":"NOT_YET_RECRUITING","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2026-03","conditions":"Hypercholesterolemia","enrollment":126},{"nctId":"NCT05977413","phase":"NA","title":"NOTIFY (New Observations Taking Information From Yesterday)","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2026-03-01","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":""},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT06863545","phase":"NA","title":"Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-22","conditions":"Coronary Artery Disease, CT Angiography, PCSK9","enrollment":3596},{"nctId":"NCT07391722","phase":"PHASE2","title":"DNV001 Injection in Patients With Hypercholesterolemia","status":"NOT_YET_RECRUITING","sponsor":"Hangzhou Dinovate Biotech Co., Ltd","startDate":"2026-02-05","conditions":"Primary Hypercholesterolemia","enrollment":120},{"nctId":"NCT07391267","phase":"NA","title":"Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-01","conditions":"Chronic Kidney Diseases, MAFLD","enrollment":90},{"nctId":"NCT07389304","phase":"PHASE1","title":"[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Lipid Profile,Blood Pressure","enrollment":100},{"nctId":"NCT04457089","phase":"EARLY_PHASE1","title":"Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer","status":"COMPLETED","sponsor":"Marc Goodman","startDate":"2021-01-25","conditions":"Recurrent Ovarian Cancer, Platinum-sensitive Ovarian Cancer","enrollment":18},{"nctId":"NCT06740552","phase":"","title":"Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-01-01","conditions":"Multivessel Coronary Artery Disease, Acute Myocardial Infarction (AMI)","enrollment":1862},{"nctId":"NCT04404166","phase":"PHASE3","title":"Phone-based Intervention Under Nurse Guidance After Stroke 2","status":"COMPLETED","sponsor":"Northern California Institute of Research and Education","startDate":"2020-10-23","conditions":"Blood Pressure, Stroke, Cardiovascular Diseases","enrollment":500},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT07378293","phase":"PHASE1","title":"Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Diabete Mellitus, Lipid Profile","enrollment":100},{"nctId":"NCT06676280","phase":"PHASE4","title":"ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography","status":"RECRUITING","sponsor":"Jung-min Ahn","startDate":"2025-07-24","conditions":"Cardiovascular Diseases","enrollment":5000},{"nctId":"NCT04894877","phase":"","title":"ISCHEMIA-EXTEND (Extended Follow-up)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2012-07","conditions":"Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease","enrollment":5391},{"nctId":"NCT07208006","phase":"NA","title":"Very Early PCSK9 Inhibition for Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-01-01","conditions":"Acute Myocardial Infarction (AMI)","enrollment":1518},{"nctId":"NCT07084051","phase":"NA","title":"Improve Medication Adherence Among Stroke Survivors in Rural Kentucky","status":"COMPLETED","sponsor":"Hend Mansoor","startDate":"2025-07-24","conditions":"Stroke (CVA) or Transient Ischemic Attack","enrollment":4},{"nctId":"NCT05782777","phase":"NA","title":"Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-04-07","conditions":"Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation","enrollment":4310},{"nctId":"NCT04735263","phase":"PHASE2","title":"Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-02-04","conditions":"Age-related Macular Degeneration","enrollment":21},{"nctId":"NCT06238466","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-01-16","conditions":"Cardiovascular","enrollment":96},{"nctId":"NCT07303699","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2026-01-03","conditions":"Pulmonary Tuberculosis (TB)","enrollment":80},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT07032389","phase":"PHASE2","title":"A Polypill for Acute Coronary Syndrome","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-12-05","conditions":"Acute Coronary Syndrome","enrollment":1000},{"nctId":"NCT05088759","phase":"NA","title":"Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-10-08","conditions":"Hyperlipemia, Mixed, ASCVD","enrollment":400},{"nctId":"NCT04679376","phase":"PHASE2","title":"Statins for the Treatment of NASH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-25","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":70},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT06431763","phase":"PHASE4","title":"A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-06-21","conditions":"Hypercholesterolemia","enrollment":402},{"nctId":"NCT07341958","phase":"NA","title":"INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-01","conditions":"Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)","enrollment":242},{"nctId":"NCT04319627","phase":"PHASE3","title":"Statins for Venous Event Reduction in Patients With Venous Thromboembolism","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-02-10","conditions":"Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome","enrollment":2700},{"nctId":"NCT07344610","phase":"","title":"Effects of Short-term Intensive Statin Therapy on Lipid Levels","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-08","conditions":"Ischemic Stroke","enrollment":800},{"nctId":"NCT06024096","phase":"PHASE4","title":"Systems Biological Assessment of Statin Effect on Vaccine Responses","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-09-20","conditions":"Vaccine Response","enrollment":63},{"nctId":"NCT06782243","phase":"NA","title":"Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-20","conditions":"Acute Coronary Syndrome","enrollment":190},{"nctId":"NCT05579626","phase":"PHASE4","title":"Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)","status":"ENROLLING_BY_INVITATION","sponsor":"Seung-Whan Lee, M.D., Ph.D.","startDate":"2023-03-14","conditions":"Pre Diabetes, ASCVD","enrollment":4000},{"nctId":"NCT07281131","phase":"NA","title":"Testing the Impact of Pre-visit Priming for Medications","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-03-02","conditions":"Deprescribing, Statin Prescribing","enrollment":1700},{"nctId":"NCT04765657","phase":"PHASE3","title":"Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-03-01","conditions":"Hypercholesterolemia","enrollment":345},{"nctId":"NCT05831085","phase":"NA","title":"Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease","status":"RECRUITING","sponsor":"Duk-Woo Park, MD","startDate":"2024-06-14","conditions":"Coronary Artery Stenosis","enrollment":1500},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT05641753","phase":"PHASE4","title":"Cholesterol Lowering and Residual Risk in Diabetes, Type 1","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-06","conditions":"Type 1 Diabetes","enrollment":125},{"nctId":"NCT05749679","phase":"NA","title":"Prevention of Renal Failure in People Followed for Type 2 Diabetes in General Practice","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-07","conditions":"Renal Insufficiency and Diabetes Mellitus","enrollment":360},{"nctId":"NCT07303816","phase":"PHASE4","title":"Statins to Prevent Cancer Associated Blood Clots","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-04-01","conditions":"Venous Thromboembolism, Cancer, Cardiovascular Events","enrollment":4000},{"nctId":"NCT04636138","phase":"NA","title":"Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2021-06-03","conditions":"HMG-CoA Reductase Inhibitor Toxicity","enrollment":5},{"nctId":"NCT07301372","phase":"PHASE4","title":"Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke","status":"RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2025-10-30","conditions":"Acute Stroke","enrollment":132},{"nctId":"NCT07286110","phase":"PHASE1","title":"Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-12-30","conditions":"Moyamoya Disease, Moyamoya Syndrome","enrollment":66},{"nctId":"NCT05764057","phase":"PHASE3","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-12","conditions":"AMI, STEMI, NSTEMI","enrollment":450},{"nctId":"NCT05488431","phase":"PHASE2","title":"Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)","status":"RECRUITING","sponsor":"Priscilla Hsue, MD","startDate":"2023-03-01","conditions":"Dyslipidemias, Cardiovascular Diseases, HIV Infections","enrollment":121},{"nctId":"NCT04951856","phase":"PHASE4","title":"Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-09-29","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI","enrollment":2166},{"nctId":"NCT06456658","phase":"NA","title":"Statin Reminders for Improving Prescribing in Primary Care","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2024-08-14","conditions":"Cholesterol, Elevated, Clinical Decision Support, Education","enrollment":3332},{"nctId":"NCT05923281","phase":"PHASE3","title":"A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance","status":"COMPLETED","sponsor":"Kowa Company, Ltd.","startDate":"2023-05-01","conditions":"Hypercholesterolemia","enrollment":71},{"nctId":"NCT07260552","phase":"","title":"Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2027-02-01","conditions":"Coronary Heart Disease","enrollment":200},{"nctId":"NCT07254221","phase":"PHASE4","title":"Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Shiraz University of Medical Sciences","startDate":"2026-02-01","conditions":"Anthracycline-induced Cardiac Toxicity, Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer","enrollment":400},{"nctId":"NCT05537064","phase":"NA","title":"Centralized Prescribing for Statins","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-11-02","conditions":"Hyperlipidemias","enrollment":1950},{"nctId":"NCT05362903","phase":"","title":"A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-01-28","conditions":"Hypercholesterolemia","enrollment":1871},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT06897566","phase":"","title":"Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-09-21","conditions":"Coronary Artery Disease, Statin Adverse Reaction, LDL Level","enrollment":1000}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ALOPECIA"},{"count":1,"reaction":"ATRIAL FIBRILLATION"},{"count":1,"reaction":"BASAL CELL CARCINOMA"},{"count":1,"reaction":"BLOOD CHLORIDE DECREASED"},{"count":1,"reaction":"DEHYDRATION"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"FLUID OVERLOAD"},{"count":1,"reaction":"GASTROENTERITIS VIRAL"},{"count":1,"reaction":"LOSS OF CONSCIOUSNESS"},{"count":1,"reaction":"PITTING OEDEMA"}],"_approvalHistory":[],"publicationCount":1830,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["statin"],"phase":"marketed","status":"active","brandName":"HMG-CoA Reductase Inhibitor","genericName":"HMG-CoA Reductase Inhibitor","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"HMG-CoA reductase inhibitors block the enzyme that catalyzes the rate-limiting step of cholesterol synthesis, reducing hepatic cholesterol production and lowering blood LDL cholesterol levels. Used for Hypercholesterolemia and dyslipidemia, Primary and secondary prevention of cardiovascular disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}